Physician profile
Philip Mulieri
NPI 1194845479
$9,098.13
in general payments reported to CMS, 2019-2025
10 companies · $600 in 2025
The $600 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,830 · 2020: $53.75 · 2021: $177 · 2022: $155 · 2023: $177 · 2024: $105 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $6,329.32 | 2019-2025 | Djo Surgical |
| Fx Shoulder Solutions, INC | $1,949.82 | 2019 | |
| Stryker Corporation | $211.78 | 2022-2025 | Aequalis Flex Revive, Blueprint Patient Specific Instrumentation, Aequalis Perform |
| Smith+Nephew, INC. | $207.07 | 2019-2025 | Trigen Intertan, Allevyn Gentle Border 10 X 10cm Ctn 10, Evos |
| Peerless Surgical INC. | $162.77 | 2024-2025 | |
| Gotham Surgical Solutions & Devices, INC. | $136.78 | 2019 | |
| Horizon Therapeutics Plc | $53.75 | 2020 | |
| Innovation Technologies INC | $16.06 | 2025 | Irrisept |
| Abbvie INC. | $15.95 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $14.83 | 2023 | Seglentis, Livalo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Mulieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.